Charting the Next Chapter: loT at the Heart of India's Pharma Transformation

With the Indian pharmaceutical industry eyeing a $130 billion valuation by 2030, digital transformation is becoming key to its growth. At the heart of this shift, IoT is revolutionising everything from R&D to patient care, manufacturing, and supply chains.

- Yuvraj Shidhaye

The Indian pharmaceutical industry, long known as the "pharmacy of the world," continues to grow its footprint within global healthcare systems. With a vision today of achieving a size of $130 billion by 2030, nearly triple its current value, the industry stands at a turning point. With precision, speed, and scale, the new standard, technologies like the Internet of Things (IoT) are back in the spotlight as enablers, poised to lead the sector to its next chapter of growth and longevity.

Reimagining R&D: Faster, Smarter, More Precise

IoT is bringing new life to pharmaceutical R&D. The costly and lengthy process of R&D in the past has now begun to become faster and more reactive. With advanced devices like "Organ-on-a-Chip," scientists can simulate human organ responses in real time, enabling them to test the efficacy of drugs faster and with greater accuracy.

Furthermore, lab equipment with sensor technology built in, connected via cloud networks, are collecting precise data on temperature, pH, and reaction timelines. Interpreted through AI, these inputs allow scientists to refine experiments in real time, reducing trial-and-error iterations and condensing time-to-discovery.

Revolutionising Clinical Trials with Real-Time Monitoring

The core of pharma, clinical development, is being transformed digitally through IoT-based devices. Wearables, smart patches, and ingestible sensors are making it possible to track trial subjects 24/7 with real-time responses in terms of vitals, drug pharmacokinetics, and dosing compliance.